KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers

Cancer Research

Volumn 58, Issue 4, 1998, Pages 753-758

  Guo, Xiao Zhong ^a   Friess, Helmut ^a   Maurer, Christoph ^a   Berberat, Pascal ^a   Tang, Wen Hao ^a   Zimmermann, Arthur ^b   Naef, Markus ^a   Graber, Hans U ^a   Korc, Murray ^c   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANTIGENS, CD; BLOTTING, NORTHERN; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS;

EID: 0032519591     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Hoelscher, A. H., Bollschweiler, E., Bumm, R., Bartels, H., Hofler, H., and Siewert, R. Prognostic factors of resection adenocarcinoma of the esophagus. Surgery (St. Louis), 118: 845-855, 1995.
3. Volpe, C. M., Koo, J., Miloro, S. M., Driscoll, D. L., Nava, H. R., and Douglass, H. O. J. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J. Am. Coll. Surg., 181: 56-64, 1995.
4. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
5. Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmadge, J. B., Liotta, L. A., and Sobel, M. E. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. (Bethesda), 80: 200-204, 1988.
6. Steeg, P. S., Bevilacqua, G., Pozzatti, R., Liotta, L. A., and Sobel, M. E. Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res., 48: 6550-6554, 1988.
7. Yamaguchi, A., Urano, T., Goi, T., Takeuchi, K., Niimoto, S., Nakagawara, G., Furukawa, K., and Shiku, H. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer (Phila.), 73: 2280-2284, 1994.
8. Hotta, H., Ross, A. H., Huebner, K., Isobe, M., Wendeborn, S., Chao, M. V., Ricciardi, R. P., Tsujimoto, T., Croce, C. M., and Koprowski, H. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res., 48: 2955-2962, 1988.
9. Metzelar, M. J., Wijngaard, P. L. J., Peters, P. J., Sixm, J. J., Nieuwenhuis, H. K., and devers, H. C. CD63 antigen. J. Biol. Chem., 266: 3239-3245, 1991.
10. Oren, R., Takahashi, S., Doss, C., Levy, R., and Levy, S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol., 10: 4007-4015, 1990.
11. Szala, S., Kasai, Y., Steplewski, Z., Rodeck, U., Koprowski, H., and Linnenbach, A. J. Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc. Natl. Acad. Sci. USA, 87: 6833-6837, 1990.
12. r 23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen. J. Immunol., 144: 3195-3200, 1990.
13. Classon, B. J., Williams, A. F., Willis, A. C., Seed, B., and Stamenkovic, I. The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J. Exp. Med., 169: 1497-1502, 1989.
14. Horejsi, V., and Vlcek, C. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett., 288: 1-4, 1991.
15. Guo, X. Z., Friess, H., Graber, H. U., Kashiwagi, M., Zimmermann, A., Korc, M., and Büchler, M. W. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res., 56: 4876-4880, 1996.
16. Hermanek, P., and Sobin, L. H. (eds.). TNM Classification of Malignant Tumors. Union Internationale Contre Cancer, Ed. 4, pp. 71-73. New York: Springer-Verlag, 1992.
17. Friess, H., Yamanaka, Y., Büchler, M. W., Beger, H. G., Kobrin, M. S., Baldwin, R. L., and Korc, M. Enhanced expression of the type II transforming growth factor-β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res., 53: 2704-2707, 1993.
18. Friess, H., Yamanaka, Y., Büchler, M. W., Ebert, M., Beger, H. G., Gold, L. I., and Korc, M. Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105: 1846-1856, 1993.
19. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Büchler, M., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest., 90: 1353-1360, 1992.
20. Friess, H., Cantero, D., Graber, H., Tang, W. H., Guo, X. Z., Kashiwagi, M., Zimmermann, A., Gold, L. I., Korc, M., and Büchler, M. W. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology, 113: 904-913, 1997.
21. Gress, T. M., Müller-Pillasch, F., Lerch, M. M., Friess, H., Büchler, M., and Adler, G. Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer, 62: 407-413, 1995.
22. Deflorin, J., Friess, H., Schobinger, S., Bründler, M. A., Schilling, M., Naef, M., Korc, M., and Büchler, M. W. Overexpression of the epidermal growth factor receptor family in gastric cancer suggests a role in tumor pathogenesis. Dig. Surg., 14: 252-259, 1997.
23. Cox, K. H., Deleon, D. V., Augerer, L. M., and Augerer, R. C. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev. Biol., 101: 485-502, 1984.
24. Liotta, L. A., Rao, C. N., and Wewer, U. M. Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem., 55: 1037-1057, 1986.
25. Ochalek, T., Nordt, F. J., Tullberg, K., and Burger, M. Correlation between cell deformability and metastatic potential in B16-F1 melanoma cell variants. Cancer Res., 48: 5124-5128, 1988.
26. Ebert, M., Yokoyama, M., Kobrin, M. S., Friess, H., Lopez, M. E., Büchler, M. W., Johnson, G. R., and Korc, M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res., 54: 3959-3962, 1994.
27. Moskal, T. L., Huang, S., Ellis, L. M., Fritsche, H. A. J., and Chakrabarty, S. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiol. Biomark. Prev., 4: 127-131, 1995.
28. Sasaki, Z., Inaji, H., Higashiyama, M., Imaoka, S., and Iwanaga, T. Expression of nucleotide diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin. Exp. Metastasis, 11: 151-158, 1993.
29. Kodera, Y., Isobe, K. I., Yamauchi, M., Kondoh, K., Kimura, N., Akiyama, S., Itoh, K., Nakashima, I., and Takagi, H. Expression of nm23 H-1 RNA levels in human gastric cancer tissues. Cancer (Phila.), 73: 259-265, 1994.
30. Wright, M. D., and Tomlinson, M. G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today, 15: 588-595, 1994.
31. Adachi, M., Taki, T., Ieki, Y., Huang, C. L., Higashiyama, M., and Miyake, M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56: 1751-1755, 1996.
32. Yu, Y., Yang, J-L., Markovic, B., Jackson, P., Yardley, G., Barrett, J., and Russell, P. J. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin. Cancer Res., 3: 1045-1049, 1997.